Keyphrases
Cervical Cancer
100%
Unvaccinated
100%
Lifetime Risk
100%
Remaining Lifetime
100%
Human Papillomavirus Negative
100%
Cervical Cancer Incidence
71%
Cervical Cancer Screening
42%
Human Papillomavirus Testing
42%
Time Reduction
42%
Cytological Diagnosis
42%
Older Women
28%
Human Papillomavirus Vaccine
28%
Screening Test
28%
High-risk Human Papillomavirus (HR-HPV)
28%
Markov Model
28%
Cervix
28%
Age-structured Population
28%
Natural History
14%
In Cancer
14%
Survey Data
14%
Papillomavirus Infections
14%
Management Decisions
14%
Cancer Risk
14%
Cancer Incidence
14%
Treatment Decisions
14%
HPV16
14%
Developed Countries
14%
Cervical Intraepithelial Neoplasia
14%
Infection Rate
14%
Paucity
14%
Oncogenic Human Papillomavirus
14%
Registry Data
14%
State Transition
14%
Screening History
14%
Hysterectomy
14%
Diminishing Returns
14%
Lesion Severity
14%
Cancer Risk Reduction
14%
Never Screened
14%
Negative Cytology
14%
HPV33
14%
HPV 52
14%
HPV18
14%
HPV31
14%
Canadian Woman
14%
Canadian Institutes of Health Research
14%
HPV58
14%
Total Hysterectomy
14%
Statistics Canada
14%
Natural Screening
14%
HPV68
14%
Co-test
14%
HPV-45
14%
HPV35
14%
Oncogenic HPV
14%
70 Years Old
14%
Medicine and Dentistry
Lifespan
100%
Cervical Cancer
100%
Wart Virus
100%
Cytotechnology
54%
Cancer Incidence
27%
Cervical Cancer Screening
27%
Screening Test
18%
Carcinogenesis
18%
Cancer Risk
18%
Cervix
18%
Hysterectomy
18%
Infection
9%
Cancer Mortality
9%
Papillomavirus Infection
9%
Cervical Intraepithelial Neoplasia
9%
Human Papillomavirus Type 16
9%
Cancer Risk Reduction
9%
Human Papillomavirus Type 18
9%
Human Papillomavirus Type 51
9%
Human Papillomavirus Type 58
9%
Human Papillomavirus Type 33
9%
Human Papillomavirus Type 35
9%
Human Papillomavirus Type 31
9%
Human Papillomavirus Type 59
9%
Human Papillomavirus Type 45
9%
Human Papillomavirus Type 52
9%